Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,045,252,665
+$7,332,090 QoQ
Shares Held
8,134,262
-5.7% QoQ
Ownership
0.330%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#36
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $6,352,612,055 across 16 Drug Manufacturers - General names. MRK ranks #3 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
27,357,486 | $1,576,338,337 | |
| 2 | LLY |
ELI LILLY & Co
|
1,035,605 | $1,242,135,802 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
8,134,262 | $1,045,252,665 | |
| 4 | JNJ |
Johnson & Johnson
|
2,907,803 | $738,494,723 | |
| 5 | ABBV |
AbbVie Inc.
|
2,015,238 | $507,114,486 | |
| 6 | PFE |
Pfizer Inc
|
18,557,891 | $446,874,011 | |
| 7 | BIIB |
Biogen Inc.
|
1,936,859 | $418,477,751 | |
| 8 | AMGN |
Amgen Inc
|
300,007 | $108,638,532 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,045,252,665 | 8,134,262 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,037,920,575 | 8,628,486 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,184,107,944 | 11,249,363 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $894,534,244 | 10,658,099 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $695,600,449 | 8,787,272 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $696,341,741 | 7,757,818 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $534,978,766 | 5,377,752 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $343,295,172 | 3,023,029 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $273,755,224 | 2,211,270 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $295,338,405 | 2,238,260 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $254,570,530 | 2,335,081 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $262,265,536 | 2,547,504 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $335,448,768 | 2,907,087 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $299,257,941 | 2,812,839 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $345,365,825 | 3,112,806 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $338,190,827 | 3,926,972 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $375,202,932 | 4,115,421 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $295,913,160 | 3,606,498 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $297,513,643 | 3,881,963 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $364,232,123 | 4,849,316 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $381,848,366 | 4,909,970 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $497,895,977 | 6,458,629 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $554,070,577 | 6,773,482 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $581,780,297 | 7,013,623 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $581,041,478 | 7,513,788 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $614,615,698 | 7,988,250 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||